News

All Categories

15 April 2013

Taking the next step beyond MOOCs

The Australian Financial Review

11 April 2013

OneVentures team ‘charmed’ by Queensland Health-IT company

Media Release

26 March 2013

Start-ups swimming in venture capital

Sydney Morning Herald

17 March 2013

Vaxxas recogniseds as 2013 BioSpectrum Asia-Pacific Emerging Company of the Year

Awards

13 March 2013

TheBestDay closes $1million dollar funding round

Uncategorized

12 March 2013

Hugh Alsop appointed Hatchtech CEO

Media Release

27 February 2013

Who’s disrupting your industry? Meet 10 start-ups eager to eat the big boys’ lunch

The Australian Financial Review

27 November 2012

Hatchtech publish data on Head Lice treatment safety study and mechanism of action

Media Release

30 October 2012

Vaxxas recognised as Janssen Ausbiotech Emergeing Company of the Year 2012

Awards

25 October 2012

Novel Pediculicide Clears Most Head Lice With 1 Application

Uncategorized

25 October 2012

Smart Sparrow a winner at Tech23

Awards

23 October 2012

Smart Sparrow a winner at Tech23 2012

Awards

08 October 2012

Vaxxas Appoints David Hoey as Company’s First CEO

Media Release

08 October 2012

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

Media Release

03 September 2012

Hatchtech announce successful End-of-Phase 2 for head lice product DeOvo™

Media Release

08 August 2012

Virtual patient gets funding injection

Sydney Morning Herald

08 August 2012

Garrett acts out NBN potential

Sydney Morning Herald

15 July 2012

Digital tools can reshape our methods

Sydney Morning Herald

17 April 2012

Best Venture Capital Investment at the 2012 Vaccine Industry Excellence Awards

Awards, Media Release

09 February 2012

Vaxxas featured in BRW Top 10 start ups to watch

Awards

08 December 2011

Vaxxas wins Australian Innovation Challenge Awards

Awards

26 October 2010

Hatchtech raises $6.3m for DeOvo™ Head Lice Phase 2b Clinical Trial

Media Release

20 September 2010

Vaxxas wins Australian Research Council Eureka Prize

Awards

09 April 2010

Feds seek more funds for innovation program

Uncategorized